Nanozymes exhibiting antioxidant activity are beneficial for the treatment of oxidative stress-associated diseases. Ruthenium nanoparticles (RuNPs) with multiple enzyme-like activities have attracted growing attention, but the relatively low antioxidant enzyme-like activities hinder their practical biomedical applications. Here, a size regulation strategy is presented to significantly boost the antioxidant

Nanovaccine-based immunotherapy (NBI) has the ability to initiate dendritic cell (DC)-mediated tumor-specific immune responses and maintain long-term antitumor immune memory. To date, the mechanism by which the mechanical properties of nanoparticles alter the functions of DCs in NBI remains largely unclear. Here, a soft mesoporous organosilica-based nanovaccine (SMONV) is prepared and the elasticity-dependent

Cancer Immunotherapy

Small 2020, 16, 1900550 DOI: 10.1002/smll.201900550 In the originally published article, there was a typo in the first funding number for the Tianjin Municipal Science and Technology Commission (18TCQNJC71500). The correct number is 18JCQNJC71500. The authors apologize for any confusion this may have caused.

Small 2022, 18, 2200395 DOI: 10.1002/smll.202200395 In the originally published article, the name of the fourth author was incorrect. “Yin-Rui Lu” should have been written as “Ying-Rui Lu.” The byline is corrected here. The authors apologize for any confusion this may have caused.